These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 29528004)

  • 41. Simultaneous Liver-Kidney Transplant: Too Many or Just Enough?
    Sung RS; Wiseman AC
    Adv Chronic Kidney Dis; 2015 Sep; 22(5):399-403. PubMed ID: 26311602
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A cost effectiveness analysis of the treatment of end stage renal failure.
    Croxson BE; Ashton T
    N Z Med J; 1990 Apr; 103(888):171-4. PubMed ID: 2109846
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Debating Organ Procurement Policy Without Illusions.
    Hippen B
    Am J Kidney Dis; 2015 Oct; 66(4):577-82. PubMed ID: 26094999
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hemodialysis versus peritoneal dialysis, which is cost-effective?
    Atapour A; Eshaghian A; Taheri D; Dolatkhah S
    Saudi J Kidney Dis Transpl; 2015 Sep; 26(5):962-5. PubMed ID: 26354569
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The organization and financing of kidney dialysis and transplant care in the United States of America.
    Hirth RA
    Int J Health Care Finance Econ; 2007 Dec; 7(4):301-18. PubMed ID: 17602296
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Organ procurement expenditures and the role of financial incentives.
    Evans RW
    JAMA; 1993 Jun 23-30; 269(24):3113-8; discussion 3155-6. PubMed ID: 8505813
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chronic Kidney Disease and Related Long-Term Complications After Liver Transplantation.
    Sharma P; Bari K
    Adv Chronic Kidney Dis; 2015 Sep; 22(5):404-11. PubMed ID: 26311603
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cost-effective treatment modalities for reducing morbidity associated with chronic kidney disease.
    Ferguson TW; Tangri N; Rigatto C; Komenda P
    Expert Rev Pharmacoecon Outcomes Res; 2015 Apr; 15(2):243-52. PubMed ID: 25661187
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Variation in resource utilization in liver transplantation at freestanding children's hospitals.
    Minneman JA; Grijalva JL; LaQuaglia MJ; Kim HB; Rangel SJ; Vakili K
    Pediatr Transplant; 2016 Nov; 20(7):921-925. PubMed ID: 27762480
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cost comparison of kidney transplant versus dialysis in Brazil.
    Silva SB; Caulliraux HM; Araújo CA; Rocha E
    Cad Saude Publica; 2016 Jun; 32(6):. PubMed ID: 27383457
    [TBL] [Abstract][Full Text] [Related]  

  • 51. End stage renal disease--the end of the road.
    Rao M
    Natl Med J India; 1992; 5(5):241-3. PubMed ID: 1302587
    [No Abstract]   [Full Text] [Related]  

  • 52. The cost of transplant graft maintenance following solid organ transplantation.
    Shireman TI; Martin JE; Whiting JF
    Transplant Proc; 2001; 33(1-2):1920-1. PubMed ID: 11267570
    [No Abstract]   [Full Text] [Related]  

  • 53. Is renal transplantation the most cost-effective and preferable therapy for patients suffering from end-stage renal disease or not?
    Niakas D; Kontodimopoulos N
    Health Policy; 2009 Mar; 89(3):329-31. PubMed ID: 18768237
    [No Abstract]   [Full Text] [Related]  

  • 54. A pocket guide to identify patients at risk for chronic kidney disease after liver transplantation.
    Weismüller TJ; Lerch C; Evangelidou E; Strassburg CP; Lehner F; Schrem H; Klempnauer J; Manns MP; Haller H; Schiffer M
    Transpl Int; 2015 May; 28(5):519-28. PubMed ID: 25581324
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Temporal Analysis of Market Competition and Density in Renal Transplantation Volume and Outcome.
    Adler JT; Yeh H; Markmann JF; Nguyen LL
    Transplantation; 2016 Mar; 100(3):670-7. PubMed ID: 26574684
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of pretransplant diabetes on short-term outcomes after liver transplantation: a national cohort study.
    Hoehn RS; Singhal A; Wima K; Sutton JM; Paterno F; Steve Woodle E; Hohmann S; Abbott DE; Shah SA
    Liver Int; 2015 Jul; 35(7):1902-9. PubMed ID: 25533420
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Diagnosis-related groups for kidney transplantation].
    Hakenberg OW
    Urologe A; 2009 Dec; 48(12):1473-7. PubMed ID: 19890621
    [TBL] [Abstract][Full Text] [Related]  

  • 58. State of renal replacement therapy services in Ghana.
    Antwi S
    Blood Purif; 2015; 39(1-3):137-40. PubMed ID: 25659989
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The organization and financing of dialysis and kidney transplantation services in New Zealand.
    Ashton T; Marshall MR
    Int J Health Care Finance Econ; 2007 Dec; 7(4):233-52. PubMed ID: 17638073
    [TBL] [Abstract][Full Text] [Related]  

  • 60. End-stage renal disease and economic incentives: the International Study of Health Care Organization and Financing (ISHCOF).
    Dor A; Pauly MV; Eichleay MA; Held PJ
    Int J Health Care Finance Econ; 2007 Sep; 7(2-3):73-111. PubMed ID: 17653860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.